Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
111M
-
Number of holders
-
214
-
Total 13F shares, excl. options
-
68.9M
-
Shares change
-
+8.07M
-
Total reported value, excl. options
-
$8.52B
-
Value change
-
+$1.08B
-
Put/Call ratio
-
0.25
-
Number of buys
-
167
-
Number of sells
-
-48
-
Price
-
$124.68
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q3 2020
241 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q3 2020.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.9M shares
of 111M outstanding shares and own 61.91% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (9.71M shares), FMR LLC (8.59M shares), Venrock Management VI, LLC (8.19M shares), VANGUARD GROUP INC (5.95M shares), Foresite Capital Management II, LLC (3.5M shares), BlackRock Inc. (3.29M shares), Foresite Capital Management I, LLC (2.75M shares), FIL Ltd (2.48M shares), 12 West Capital Management LP (1.92M shares), and Invesco Ltd. (1.79M shares).
This table shows the top 214 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.